REPORTS

Let’s Pullulate and Expand Your Business

Global Alzheimer's Disease Therapeutics and Diagnostics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 10, 2020  |  147 PAGES  |  REPORT CODE: CMM340693
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2016, an estimated 5.4 million Americans of all ages have Alzheimer's disease. One in nine people aged 65 and above has Alzheimer's disease. By 2050, the number of people aged 65 and above affected with Alzheimer's disease is expected to nearly triple, from 5.2 million to an expected 13.8 million, excluding the development of medical advances to avert or cure the disease. The mortality rates due to Alzheimer’s disease are quite high. Between 2000 and 2013, deaths due to heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, while deaths from AD increased 71% in the U.S. Similarly, According to Alzheimer’s disease International in 2015, there are an estimated 46.8 million people worldwide living with dementia and is further expected to grow in future. Thus, there is an increasing in the demand for Alzheimer’s therapeutics and diagnostics worldwide. Population aging across the globe is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia. Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations. One of the significant trend observed in this market is collaboration of the existing players.  Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates which is further expected to propel the demand.

The Alzheimer's Disease Therapeutics and Diagnostics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period. The research provides insights for the global Alzheimer's Disease Therapeutics and Diagnostics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Alzheimer's Disease Therapeutics and Diagnostics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Alzheimer's Disease Therapeutics and Diagnostics Market Segmentations:

By Players:

  • Namenda

  • Aricept

  • Exelon

  • Solanezumab

  • Gantenerumab

  • Verubecestat

  • Pfizer

  • Eisai

  • Actavis

  • Lundbeck

  • Daiichi Sankyo

  • Novartis

  • TauRx

By Types:

  • Biomarkers

  • Cholinesterase inhibitors

  • NMDA receptor antagonists

  • Brain imaging

  • Blood tests

By End-User:

  • Drugs Market

  • Diagnostics Market

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Alzheimer's Disease Therapeutics and Diagnostics Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Biomarkers from 2014 to 2026

    • 1.3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Cholinesterase inhibitors from 2014 to 2026

    • 1.3.3 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of NMDA receptor antagonists from 2014 to 2026

    • 1.3.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Brain imaging from 2014 to 2026

    • 1.3.5 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Blood tests from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Drugs Market from 2014 to 2026

    • 1.4.2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics Market from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Alzheimer's Disease Therapeutics and Diagnostics Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Alzheimer's Disease Therapeutics and Diagnostics by Major Types

    • 3.4.1 Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Biomarkers

    • 3.4.2 Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Cholinesterase inhibitors

    • 3.4.3 Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of NMDA receptor antagonists

    • 3.4.4 Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Brain imaging

    • 3.4.5 Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Blood tests

4 Segmentation of Alzheimer's Disease Therapeutics and Diagnostics Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Alzheimer's Disease Therapeutics and Diagnostics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Alzheimer's Disease Therapeutics and Diagnostics in Drugs Market

    • 4.4.2 Market Size and Growth Rate of Alzheimer's Disease Therapeutics and Diagnostics in Diagnostics Market

5 Market Analysis by Major Regions

  • 5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Production Analysis by Major Regions

  • 5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Analysis by Major Regions

  • 5.3 Global Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

6 Product Commodity of Alzheimer's Disease Therapeutics and Diagnostics Market in Major Countries

  • 6.1 Top 5 Export Countries in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis

  • 7.1 North America Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 7.2 North America Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 7.3 North America Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 7.3.1 United States Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 7.3.2 Canada Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 7.3.3 Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

8 Europe Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis

  • 8.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 8.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 8.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 8.3.1 Germany Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.2 UK Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.3 France Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.4 Italy Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.6 Spain Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.7 Belgium Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.8 Poland Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.9 Russia Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 8.3.10 Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

9 Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis

  • 9.1 Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 9.2 Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 9.3.1 China Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.2 Japan Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.4 India Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 9.3.6 South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

10 Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 10.3.2 Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 10.3.3 Nigeria Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

    • 10.3.4 South Africa Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate 

    • 10.3.5 Argentina Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Namenda

    • 11.1.1 Namenda Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Aricept

    • 11.2.1 Aricept Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Exelon

    • 11.3.1 Exelon Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Solanezumab

    • 11.4.1 Solanezumab Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Gantenerumab

    • 11.5.1 Gantenerumab Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Verubecestat

    • 11.6.1 Verubecestat Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Pfizer

    • 11.7.1 Pfizer Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Eisai

    • 11.8.1 Eisai Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Actavis

    • 11.9.1 Actavis Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Lundbeck

    • 11.10.1 Lundbeck Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Daiichi Sankyo

    • 11.11.1 Daiichi Sankyo Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Novartis

    • 11.12.1 Novartis Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 TauRx

    • 11.13.1 TauRx Company Profile and Recent Development

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 77 Figures and 185 Tables)

  • Figure Product Picture

  • Figure Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Biomarkers from 2014 to 2026

  • Figure Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Cholinesterase inhibitors from 2014 to 2026

  • Figure Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of NMDA receptor antagonists from 2014 to 2026

  • Figure Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Brain imaging from 2014 to 2026

  • Figure Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Blood tests from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Drugs Market from 2014 to 2026

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Market Size and Growth Rate of Diagnostics Market from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Alzheimer's Disease Therapeutics and Diagnostics Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Alzheimer's Disease Therapeutics and Diagnostics

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Alzheimer's Disease Therapeutics and Diagnostics by Different Types from 2014 to 2026

  • Table Consumption Share of Alzheimer's Disease Therapeutics and Diagnostics by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Biomarkers

  • Figure Market Size and Growth Rate of Cholinesterase inhibitors

  • Figure Market Size and Growth Rate of NMDA receptor antagonists

  • Figure Market Size and Growth Rate of Brain imaging

  • Figure Market Size and Growth Rate of Blood tests

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Alzheimer's Disease Therapeutics and Diagnostics by Different End-Users from 2014 to 2026

  • Table Consumption Share of Alzheimer's Disease Therapeutics and Diagnostics by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Drugs Market

  • Figure Market Size and Growth Rate of Diagnostics Market

  • Table Global Alzheimer's Disease Therapeutics and Diagnostics Production by Major Regions

  • Table Global Alzheimer's Disease Therapeutics and Diagnostics Production Share by Major Regions

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Production Share by Major Regions in 2014

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Production Share by Major Regions in 2018

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Production Share by Major Regions in 2026

  • Table Global Alzheimer's Disease Therapeutics and Diagnostics Consumption by Major Regions

  • Table Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Regions

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Regions in 2014

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Regions in 2018

  • Figure Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Regions in 2026

  • Table North America Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Europe Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Alzheimer's Disease Therapeutics and Diagnostics market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Alzheimer's Disease Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table North America Alzheimer's Disease Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table North America Alzheimer's Disease Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure United States Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure Germany Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure France Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure China Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandAlzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure India Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Alzheimer's Disease Therapeutics and Diagnostics Consumption Share by Major Countries in 2026

  • Figure GCC Countries Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Alzheimer's Disease Therapeutics and Diagnostics Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Namenda

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Namenda

  • Figure Sales and Growth Rate Analysis of Namenda

  • Figure Revenue and Market Share Analysis of Namenda

  • Table Product and Service Introduction of Namenda

  • Table Company Profile and Development Status of Aricept

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aricept

  • Figure Sales and Growth Rate Analysis of Aricept

  • Figure Revenue and Market Share Analysis of Aricept

  • Table Product and Service Introduction of Aricept

  • Table Company Profile and Development Status of Exelon

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Exelon

  • Figure Sales and Growth Rate Analysis of Exelon

  • Figure Revenue and Market Share Analysis of Exelon

  • Table Product and Service Introduction of Exelon

  • Table Company Profile and Development Status of Solanezumab

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Solanezumab

  • Figure Sales and Growth Rate Analysis of Solanezumab

  • Figure Revenue and Market Share Analysis of Solanezumab

  • Table Product and Service Introduction of Solanezumab

  • Table Company Profile and Development Status of Gantenerumab

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gantenerumab

  • Figure Sales and Growth Rate Analysis of Gantenerumab

  • Figure Revenue and Market Share Analysis of Gantenerumab

  • Table Product and Service Introduction of Gantenerumab

  • Table Company Profile and Development Status of Verubecestat

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Verubecestat

  • Figure Sales and Growth Rate Analysis of Verubecestat

  • Figure Revenue and Market Share Analysis of Verubecestat

  • Table Product and Service Introduction of Verubecestat

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Eisai

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

  • Figure Sales and Growth Rate Analysis of Eisai

  • Figure Revenue and Market Share Analysis of Eisai

  • Table Product and Service Introduction of Eisai

  • Table Company Profile and Development Status of Actavis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

  • Figure Sales and Growth Rate Analysis of Actavis

  • Figure Revenue and Market Share Analysis of Actavis

  • Table Product and Service Introduction of Actavis

  • Table Company Profile and Development Status of Lundbeck

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lundbeck

  • Figure Sales and Growth Rate Analysis of Lundbeck

  • Figure Revenue and Market Share Analysis of Lundbeck

  • Table Product and Service Introduction of Lundbeck

  • Table Company Profile and Development Status of Daiichi Sankyo

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

  • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

  • Figure Revenue and Market Share Analysis of Daiichi Sankyo

  • Table Product and Service Introduction of Daiichi Sankyo

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of TauRx

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TauRx

  • Figure Sales and Growth Rate Analysis of TauRx

  • Figure Revenue and Market Share Analysis of TauRx

  • Table Product and Service Introduction of TauRx


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top